{"id":"https://genegraph.clinicalgenome.org/r/2d38dd5e-49a6-4d46-90a9-734ee150013fv1.1","type":"EvidenceStrengthAssertion","dc:description":"KCNJ2 encodes the alpha subunit of Ik1, the inward rectifier cardiac potassium channel. Pathogenic variants in KCNJ2 are the cause of Andersen-Tawil Syndrome (ATS), a multisystem disorder whose manifestations include dysmorphic features and periodic paralysis. Although patients with ATS are at risk of developing ventricular arrhythmias, these are not typically torsades de pointes, the hallmark of LQTS. Furthermore, ECGs of patients with ATS demonstrate QT-U prolongation and not QT prolongation. Accordingly, the Expert Panel classified the level of evidence for this association as limited. \nNote: All LQTS genes were curated by 3 separate blinded teams. The evidence and scores reached by these 3 teams were reviewed by the LQTS Clinical Domain Expert Panel. For a detailed discussion of this group's work and the separate scores of the 3 teams please see \"Adler et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 2020;141(6):418-428. doi: 10.1161/CIRCULATIONAHA.119.043132â€","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/2d38dd5e-49a6-4d46-90a9-734ee150013f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2020-12-15T00:25:35.799Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2021-01-08T19:17:03.094Z","role":"Publisher"}],"curationReasonDescription":"See evidence summary","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bc1f6e3-702c-440c-8139-4a82ab55cfe2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33194a15-46e5-4036-8550-f93025316137","type":"Finding","dc:description":"The KCNJ2 -containing channels (known as Kir2.1 in the paper) contribute to cell excitability in heart, brain and skeletal muscle. LQT prolongs the interval required for cardiac myocytes to repolarize, either by enhancing depolarization or reducing repolarization of the membranes. Reducing the function of the KCNJ2 channels would reduce the repolarization rate, as shown in the biochem experiments and this happens in an autosomal dominant way.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","rdfs:label":"Patch clamp","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0b1645c-2d57-415a-9a6c-13e49cfd0dd4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b6a2f46-e415-49c6-8584-38530731b3a3","type":"FunctionalAlteration","dc:description":"The mutant forms of KCNJ2 were cloned and transfected into COS-7 cells. Following expression, cells with the mutant forms of the gene showed complete lack of inwardly rectifying current, while cells transfected with WT KCNJ2 showed \"classical\" current levels.  Co-expression of wildtype and mutant forms of the KCNJ2 protein still showed loss of current, suggesting a dominant negative effect.  Assembly and trafficking of the mutant forms of the protein appear normal; therefore the impact is on function.  Experiments were repeated in HIK-293 cells, which derive from muscle, because the disease also shows effects on muscle- channel activity was also abolished in these cells with these mutants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15831539","rdfs:label":"COS cell culture electrophysiology"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f6997dbd-02ef-4581-9b32-7939e934e9d0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b409838-cb53-4926-945c-93f576af2e13","type":"FunctionalAlteration","dc:description":"current reduction 95%","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22589293","rdfs:label":"Cellular electrophysiological experiments"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b48f7804-e195-43d9-9d3d-a5d8741cfb12","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24a4216e-4674-495a-b138-62631d195718","type":"FunctionalAlteration","dc:description":"Confocal imaging confirmed that the variant KCNJ2 protein did not localize appropriately to the plasma membrane, although this is partially restored by coexpression with wildtype KCNJ2. In CHO cells, the mutant form of the protein could not yield measurable K+ inward rectification current.  This was partially alleviated by co-transfecting with wildtype, but not entirely, leading the authors to suggest a partially dominant negative effect of the mutation, in keeping with AD mode of inheritance.  Additionally, the heterologous channels exhibited increased inward rectification in the presence of increasing Mg++.\n\nIn this paper the variant in the proband is associated with prolonged QT (500ms) with prominant U waves as well as the muscle paralysis phenotype of ATS.  However, her daughter was noted in the discussion to have the same variant and borderline QT interval (440ms).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17582433","rdfs:label":"imaging and electrophysiology"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/364ae696-d015-4a9c-9cd9-6e22de749156","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f1328a1-adc9-426e-b976-a30ce93a8f4f","type":"FunctionalAlteration","dc:description":"20-25% reduced current amplitudes as a result of defective gating","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23644778","rdfs:label":"Localization and electrphysiological properties"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/14daecf4-9e0d-47ce-b08f-23c2d9d51387","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd81e5b6-3745-4d3c-afdc-90b78740b936","type":"FunctionalAlteration","dc:description":"Potassium current (Ik) decreased by 28% and 50% by the T75A and the deltaFQ163-164 mutation, respectively.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15276028","rdfs:label":"Volatge-clamp"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e9e65e67-0aac-491c-9e99-5f9d9c479d61","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a211db7-8f30-4431-99ff-d815a6f5916a","type":"FunctionalAlteration","dc:description":"The mutant version transfected on its own resulted in abolishment of inward rectifying current.  Co-transfection with WT, to mimic the heterozygous situation, resulted in reduced current, suggesting a dominant negative effect.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16541386","rdfs:label":"HEK293 electrophysiology"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1dd26247-d05c-46ba-8b60-acde2af93c6c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac55d963-b9b3-46cf-ae2f-35d3f18eb0eb","type":"Finding","dc:description":"The wildtype protein directly interacts with the mutant form (demonstrated by FRET experiments) and partially restores the proper function by this interaction.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21493816","rdfs:label":"CHO eletrophysiology","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/09dea9ec-69ce-4387-890f-51f242da49c7_family_segregation","type":"FamilyCosegregation","dc:description":"Associated with ATS, not pure LQT","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","rdfs:label":"4415","estimatedLodScore":3.61,"family":{"id":"https://genegraph.clinicalgenome.org/r/09dea9ec-69ce-4387-890f-51f242da49c7","type":"Family","rdfs:label":"4415"},"meetsInclusionCriteria":false,"phenotype":{"id":"obo:HP_0001657"},"phenotypePositiveAllelePositive":5},{"id":"https://genegraph.clinicalgenome.org/r/48c67799-c8d0-44ad-941c-f96804067057_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23644778","rdfs:label":"#610","family":{"id":"https://genegraph.clinicalgenome.org/r/48c67799-c8d0-44ad-941c-f96804067057","type":"Family","rdfs:label":"#610","member":{"id":"https://genegraph.clinicalgenome.org/r/f1ce71fc-7177-4d8a-bd91-fe9c12e4753c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23644778","rdfs:label":"#N318S","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":41,"detectionMethod":"540 unrelated probands parallel sequencing approach (LQTS1-LQTS8) and in 710 step wise sequencing approach","phenotypeFreeText":"VF, QTc 482, sinus tachycardia, no U wave","phenotypes":"obo:HP_0005184","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ae5f31f8-d315-4000-96aa-1b4a6f58af7e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23644778","allele":{"id":"https://genegraph.clinicalgenome.org/r/19f6dcbb-2ae2-4486-8039-1eceea657ade","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000891.3(KCNJ2):c.953A>G (p.Asn318Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346055"}}}}},"phenotypeFreeText":"VF, QTc 482, sinus tachycardia, no U wave","phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0005184","proband":{"id":"https://genegraph.clinicalgenome.org/r/f1ce71fc-7177-4d8a-bd91-fe9c12e4753c"}},{"id":"https://genegraph.clinicalgenome.org/r/8e8e1f1b-e064-4fcd-bcb9-a69b2cbebaa7_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15276028","rdfs:label":"#family1","family":{"id":"https://genegraph.clinicalgenome.org/r/8e8e1f1b-e064-4fcd-bcb9-a69b2cbebaa7","type":"Family","rdfs:label":"#family1"},"phenotype":{"id":"obo:HP_0005184"},"phenotypePositiveAllelePositive":1},{"id":"https://genegraph.clinicalgenome.org/r/7a72652a-3f7a-4304-bf63-09825b3651ba_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15276028","rdfs:label":"#family2","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/7a72652a-3f7a-4304-bf63-09825b3651ba","type":"Family","rdfs:label":"#family2","member":{"id":"https://genegraph.clinicalgenome.org/r/f397f916-b3c2-4527-a52a-4d22c33a3077","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15276028","rdfs:label":"II-1","ageType":"AgeAtReport","ageValue":40,"detectionMethod":"DHPLC, PCR, sequencing","firstTestingMethod":"Denaturing gradient gel","previousTesting":true,"previousTestingDescription":"KCNQ1, HERG, SCN5A, KCNE1 , KCNE2","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d934f042-4692-430f-898a-c4e6ba996803_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15276028","allele":{"id":"https://genegraph.clinicalgenome.org/r/089f98e7-7679-4719-a348-93dd450fe26d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"KCNJ2, 12-BP DEL, NT513","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8921"}}}}},"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0005184","proband":{"id":"https://genegraph.clinicalgenome.org/r/f397f916-b3c2-4527-a52a-4d22c33a3077"}},{"id":"https://genegraph.clinicalgenome.org/r/0c21ed0e-45df-4fa3-862c-280ee5f8996a_family_segregation","type":"FamilyCosegregation","dc:description":"This variant does not segregate with the LQT phenotype, but rather with ATS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12148092","rdfs:label":"Andelfinger et al","family":{"id":"https://genegraph.clinicalgenome.org/r/0c21ed0e-45df-4fa3-862c-280ee5f8996a","type":"Family","rdfs:label":"Andelfinger et al"},"meetsInclusionCriteria":false,"phenotype":{"id":"obo:HP_0004308"},"phenotypePositiveAllelePositive":23,"publishedLodScore":3.6},{"id":"https://genegraph.clinicalgenome.org/r/63fc465b-a00a-4426-aeea-b539c732edce_family_segregation","type":"FamilyCosegregation","dc:description":"Associated with ATS, not pure LQT","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16571646","rdfs:label":"Case study Lu et al","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/63fc465b-a00a-4426-aeea-b539c732edce","type":"Family","rdfs:label":"Case study Lu et al"},"meetsInclusionCriteria":false,"phenotype":{"id":"obo:HP_0011675"},"phenotypePositiveAllelePositive":3},{"id":"https://genegraph.clinicalgenome.org/r/7bea7e43-80f2-452c-a3af-c81330ba21ae_proband_segregation","type":"FamilyCosegregation","dc:description":"Mother prolonged QT and u wave. Only one segregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24395924","rdfs:label":"LQTS","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/7bea7e43-80f2-452c-a3af-c81330ba21ae","type":"Family","rdfs:label":"LQTS","member":{"id":"https://genegraph.clinicalgenome.org/r/3db1acee-5ab1-4db4-8033-f09b6ac7e0cf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24395924","rdfs:label":"#A","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":36,"detectionMethod":"12x135K custom CGH array 101 genes","firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"prolonged QT, abnormal T waves.","previousTesting":true,"previousTestingDescription":"LQTS1,2,3,5,6, and 7","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d7062d07-c528-45f1-9fad-1e398d444620_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24395924","allele":{"id":"https://genegraph.clinicalgenome.org/r/089f98e7-7679-4719-a348-93dd450fe26d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0005184","obo:HP_0001645"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3db1acee-5ab1-4db4-8033-f09b6ac7e0cf"}},{"id":"https://genegraph.clinicalgenome.org/r/4f0f9df4-f4e1-48c9-a57f-09a7737b5e53_proband_segregation","type":"FamilyCosegregation","dc:description":"There is only one segregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28003625","rdfs:label":"family 1","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/4f0f9df4-f4e1-48c9-a57f-09a7737b5e53","type":"Family","rdfs:label":"family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/ce1208d7-c6b7-46ee-a75d-9c9b2f07ff02","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28003625","rdfs:label":"II-1 family 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":16,"detectionMethod":"Targeted resequencing for 14 genes known to be involved was performed by NGS. All mutations were validated by Sanger sequencing in probands and then the genotype-phenotype correlation of each mutation was evaluated by family segregation study using a Beckman Coulter CEQTM 8000 Genetic Analysis System.","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"The female proband, 20 years of age with onset at 16 years, complained of syncope and premature ventricular beats. Examination showed a heart-rate-corrected QT interval (QTc) > 450 msec and QTcmax of 530 msec. The patient underwent implantation of a cardioverter-defibrillator (ICD).","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b28a292e-afa3-490d-bd4d-56ccd839a6cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28003625","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ca00d87-7a60-4a3c-89ca-b5393cd9cbc5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000891.3(KCNJ2):c.245G>A (p.Arg82Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA329657"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"The female proband, 20 years of age with onset at 16 years, complained of syncope and premature ventricular beats. Examination showed a heart-rate-corrected QT interval (QTc) > 450 msec and QTcmax of 530 msec. The patient underwent implantation of a cardioverter-defibrillator (ICD). The sister is healthy, without clinical manifestations and normal QTc. The mother asymptomatic had a 12- lead ECG showed QTc > 460 msec and scored an intermediate probability of LQTS by the Schwartz-Moss system.","phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ce1208d7-c6b7-46ee-a75d-9c9b2f07ff02"}},{"id":"https://genegraph.clinicalgenome.org/r/ee0ba0de-4c78-4e83-9a6c-195fe89dad0a_proband_segregation","type":"FamilyCosegregation","dc:description":"This is not a segregation study- this is a de novo variant.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21148745","rdfs:label":"Barajas-Martinez et al","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ee0ba0de-4c78-4e83-9a6c-195fe89dad0a","type":"Family","rdfs:label":"Barajas-Martinez et al","member":{"id":"https://genegraph.clinicalgenome.org/r/1f3b0f92-6bf9-415e-844e-549aa6fdf447","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21148745","rdfs:label":"II-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"detectionMethod":"Sequencing of KCNJ2","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001999","obo:HP_0011675"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/dda4c53d-ff7e-40eb-a8a6-455426428f0e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21148745","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc4a314a-82d8-4a97-815a-735872d3e061","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000891.3(KCNJ2):c.779G>C (p.Arg260Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/67587"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0011675","proband":{"id":"https://genegraph.clinicalgenome.org/r/1f3b0f92-6bf9-415e-844e-549aa6fdf447"}},{"id":"https://genegraph.clinicalgenome.org/r/7f53bf0c-1867-4606-97cc-29510b96390d_proband_segregation","type":"FamilyCosegregation","dc:description":"This variant segregated with the Anderson-Tawil syndrome phenotypes of prolonged QT, facial dysmorphology.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20111058","rdfs:label":"Chan et al","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/7f53bf0c-1867-4606-97cc-29510b96390d","type":"Family","rdfs:label":"Chan et al","member":{"id":"https://genegraph.clinicalgenome.org/r/102ec0b6-cd62-445f-8de0-5e61b1f67b39","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20111058","rdfs:label":"Chan et al II-4","detectionMethod":"Not provided.","phenotypes":["obo:HP_0001999","obo:HP_0001657","obo:HP_0003768"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ae67a72f-fb92-40c8-92e7-43b6277c96d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20111058","allele":{"id":"https://genegraph.clinicalgenome.org/r/6af0db1a-93e7-42ce-ba4b-095b88eeeec9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000891.3(KCNJ2):c.575C>T (p.Thr192Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/67582"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0003768","proband":{"id":"https://genegraph.clinicalgenome.org/r/102ec0b6-cd62-445f-8de0-5e61b1f67b39"}},{"id":"https://genegraph.clinicalgenome.org/r/294bd331-d17d-495c-bdab-f59ce601a0d0_family_segregation","type":"FamilyCosegregation","dc:description":"Associated with ATS, not pure LQT","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29017447","rdfs:label":"Scheiper et al","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/294bd331-d17d-495c-bdab-f59ce601a0d0","type":"Family","rdfs:label":"Scheiper et al"},"meetsInclusionCriteria":false,"phenotype":{"id":"obo:HP_0003768"},"phenotypeFreeText":"Ventricular premature beats","phenotypePositiveAllelePositive":4}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1783214a-bb3d-429b-a4aa-fd1f6bb5ac8d_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8422ad5c-b9e1-4459-baa6-e8360da6b691","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22589293","rdfs:label":"#16","ageType":"AgeAtReport","ageUnit":"Years","ageValue":46,"detectionMethod":"DHPLC, PCR, sequencing","firstTestingMethod":"Denaturing gradient gel","phenotypeFreeText":"QTc/QUc 553/680","phenotypes":"obo:HP_0005184","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1783214a-bb3d-429b-a4aa-fd1f6bb5ac8d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22589293","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ca00d87-7a60-4a3c-89ca-b5393cd9cbc5"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ae5f31f8-d315-4000-96aa-1b4a6f58af7e_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1ce71fc-7177-4d8a-bd91-fe9c12e4753c"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d934f042-4692-430f-898a-c4e6ba996803_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f397f916-b3c2-4527-a52a-4d22c33a3077"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ae67a72f-fb92-40c8-92e7-43b6277c96d1_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant segregates with ATS, not with pure LQT","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/102ec0b6-cd62-445f-8de0-5e61b1f67b39"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d7062d07-c528-45f1-9fad-1e398d444620_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3db1acee-5ab1-4db4-8033-f09b6ac7e0cf"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b28a292e-afa3-490d-bd4d-56ccd839a6cb_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce1208d7-c6b7-46ee-a75d-9c9b2f07ff02"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e47faf4e-8afd-4b35-83d5-331c167840be_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf7ceeb6-9b81-488e-8f35-7fc14e753fbc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22589293","rdfs:label":"#20","ageType":"AgeAtReport","ageUnit":"Years","ageValue":24,"detectionMethod":"DHPLC, PCR, sequencing","firstTestingMethod":"Denaturing gradient gel","phenotypes":"obo:HP_0005184","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e47faf4e-8afd-4b35-83d5-331c167840be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22589293","allele":{"id":"https://genegraph.clinicalgenome.org/r/089f98e7-7679-4719-a348-93dd450fe26d"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dda4c53d-ff7e-40eb-a8a6-455426428f0e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant segregates with ATS, not purely with LQT syndrome","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f3b0f92-6bf9-415e-844e-549aa6fdf447"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5dc2acbc-8dbe-4142-8f71-89f1576dde08_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a8be965-b34c-43f5-a553-a4bb5c2091e4_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Associated with ATS, not pure LQT","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b9a806a-1306-4302-b676-237a8a0f9962","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","rdfs:label":"K2679 2-I","detectionMethod":"Sanger sequencing of the coding region of the KCNJ2 gene.","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0011675","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6a8be965-b34c-43f5-a553-a4bb5c2091e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","allele":{"id":"https://genegraph.clinicalgenome.org/r/8439a84e-8868-4c44-bc78-d1099daa1577","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000891.3(KCNJ2):c.652C>T (p.Arg218Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8919"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/bfb84dae-b6ba-4385-b15a-5a28b99d753f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Associated with ATS, not pure LQT","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fcd1e8ae-69a4-401f-8960-3205193f0627","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","rdfs:label":"K2681 2-I","detectionMethod":"Sanger sequencing of the coding region of KCNJ2","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0011675","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/bfb84dae-b6ba-4385-b15a-5a28b99d753f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","allele":{"id":"https://genegraph.clinicalgenome.org/r/8439a84e-8868-4c44-bc78-d1099daa1577"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/34becb82-ab09-4afa-b845-a1d7dede4ba9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Associated with ATS, not pure LQT","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4434bbd-ab1c-44ff-94c0-33d307c3cf2e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","rdfs:label":"K3856 2-I","detectionMethod":"Sanger sequencing of the KCNJ2 gene","firstTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/34becb82-ab09-4afa-b845-a1d7dede4ba9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","allele":{"id":"https://genegraph.clinicalgenome.org/r/38d08e5c-778c-4055-8222-176862bf7041","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000891.3(KCNJ2):c.430G>A (p.Gly144Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/67573"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cdae9127-943f-4d64-8e6a-8bb67a4e13c5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Associated with ATS, not pure LQT","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efa27380-e255-4ef1-914c-ac0745eecc01","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","rdfs:label":"K6515 2-I","detectionMethod":"Sanger sequencing of the coding region of KCNJ2","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0011675","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cdae9127-943f-4d64-8e6a-8bb67a4e13c5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11371347","allele":{"id":"https://genegraph.clinicalgenome.org/r/8439a84e-8868-4c44-bc78-d1099daa1577"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Limited","sequence":1771,"specifiedBy":"GeneValidityCriteria8","strengthScore":6.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/VNrwD__apQg","type":"GeneValidityProposition","disease":"obo:MONDO_0002442","gene":"hgnc:6263","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_5dc2acbc-8dbe-4142-8f71-89f1576dde08-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}